Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma
NCT05221398
·
clinicaltrials.gov ↗
COMPLETED
Status
517
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Immune Checkpoint Inhibitors Based Adjuvant therapy
OTHER:
Active surveillance
Sponsor
Guangxi Medical University